Preoperative Biliary Drainage in Severe Hyperbilirubinemia

Threshold for Drainage

The critical bilirubin level at which pre‑operative biliary drainage becomes mandatory is ≥ 14.6 mg/dL (≈ 250 μmol/L); this cutoff is derived from high‑quality evidence linking higher levels to increased peri‑operative mortality and morbidity. [Evidence level: high] 1
The 2023 ESMO pancreatic cancer guideline explicitly recommends endoscopic drainage for any patient with bilirubin > 250 μmol/L. [Guideline recommendation] 1
The 2012 ERAS Society guideline advises against routine drainage only when bilirubin is < 250 μmol/L, thereby supporting drainage for values at or above this threshold. [Guideline recommendation] 2, 3, 4

Surgery should be delayed > 2 weeks after presentation when initial bilirubin exceeds 250 μmol/L, to allow adequate biliary decompression. [Guideline recommendation] 1
This delay permits correction of coagulopathy (target INR < 1.5, platelets > 50 000/µL) before any percutaneous approach. [Guideline recommendation] 5
Additional benefits of the delay include improvement in hepatic synthetic function and reduction of systemic inflammatory state. [Guideline recommendation] 7, 6

Endoscopic retrograde cholangiopancreatography (ERCP) with stenting is the preferred first‑line drainage method because it carries a significantly lower bleeding risk than percutaneous transhepatic biliary drainage (PTBD). [Guideline recommendation] 5
PTBD is reserved for cases where ERCP fails or is technically infeasible. [Guideline recommendation] 5
In hilar obstruction, bilateral drainage may be necessary to achieve adequate decompression of ≥ 50 % of functional liver parenchyma. [Guideline recommendation] 6

Assess coagulation status (PT/INR, PTT, platelet count) immediately before any drainage procedure, as severe hyperbilirubinemia often induces coagulopathy via cholestasis and vitamin K deficiency. [Guideline recommendation] 5
Administer vitamin K before attributing a prolonged INR solely to liver dysfunction, because many coagulation abnormalities are correctable. [Guideline recommendation] 5
Prophylactic antibiotics should be given at the time of drainage placement to mitigate the high infection risk associated with biliary instrumentation. [Guideline recommendation] 6

The therapeutic goal is to reduce serum bilirubin to < 5 mg/dL before definitive surgery; weekly bilirubin measurements are advised during the drainage period to track progress. [Guideline recommendation] 7
Routine weekly monitoring should also include total and direct bilirubin, AST/ALT, alkaline phosphatase, GGT, albumin, and PT/INR to evaluate hepatic recovery. [Guideline recommendation] 7
Clinical surveillance for cholangitis (fever, leukocytosis, inflammatory markers) is essential throughout the drainage interval. [Guideline recommendation] 6